Target intelligence / Profile preview

Forkhead box P3-bound regulatory DNA sequences (FOXP3-bound DNA)

Target
FOXP3-bound DNA
Molecular classification
Transcription factor binding site, Regulatory DNA sequence, Genomic locus
01

Overview

Forkhead box P3 (FOXP3)-bound regulatory DNA sequences are specific genomic regions, including promoters and enhancers, that are physically occupied by the FOXP3 transcription factor to orchestrate the gene expression program of regulatory T cells (Tregs). These sequences are essential for maintaining immune tolerance and preventing autoimmunity, as FOXP3 binds to them—often in cooperation with partners like NFAT or Runx1—to repress pro-inflammatory genes such as IL2 and activate suppressive markers like CTLA4 and CD25. The binding sites are typically characterized by the 'GTAAACA' motif, and their accessibility is often regulated by epigenetic modifications. Mutations in the FOXP3 DNA-binding domain (FKH domain) disrupt these interactions, leading to severe autoimmune disorders like IPEX syndrome. In the context of cancer, FOXP3-mediated regulation in Tregs contributes to an immunosuppressive tumor microenvironment, making the disruption of FOXP3-DNA binding a significant therapeutic objective. Current drug development strategies include antisense oligonucleotides to reduce FOXP3 levels and specialized peptides designed to inhibit FOXP3's ability to bind to these regulatory DNA sequences or its essential co-regulatory partners.

Other names
FOXP3 binding sitesFOXP3 response elementsFOXP3-regulated genomic regionsFOXP3-occupied promotersTreg-specific regulatory sequences
02

Mechanism of action

Modulation of FOXP3-mediated gene transcription through inhibition of DNA binding, disruption of FOXP3-transcription factor complexes, or antisense-mediated knockdown of FOXP3 expression.

03

Biological functions

Immune response regulationT-cell differentiationGene expression regulationImmune tolerance maintenanceChromatin architecture modulation
04

Disease associations

Autoimmune diseaseCancerIPEX syndromeInflammationAllergic dysregulation
05

Safety considerations

Systemic immunosuppressionRisk of severe autoimmunityOff-target effects on non-regulatory T cell subsetsPotential for cytokine release syndrome
06

Interacting drugs

AZD8701

4 more in the full profile.

07

Biomarkers

FOXP3 expression levelsTreg-specific demethylated region (TSDR) methylation statusCD25 (IL2RA) expressionCTLA-4 expressionGITR expression

Beyond the preview

Go deeper on Forkhead box P3-bound regulatory DNA sequences (FOXP3-bound DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forkhead box P3-bound regulatory DNA sequences (FOXP3-bound DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call